There is substantial evidence supporting the effectiveness of longer-term treatments for individuals with personality disorder, and particularly borderline personality disorder.1 Yet, there is a ...

Adjustment disorder refers to a short-term and mild state of distress and emotional disturbance that occurs in response to significant life changes or environmental shifts. It is often accompanied by ...

Background: Adjustment Disorder (AD) is a psychological condition that arises as a response to identifiable stressors, leading to emotional distress and functional impairment. This cross-sectional ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I am continuing my ongoing series about the ...

Relationships come with their fair share of ups and downs. Disagreements, emotional distance, and stress are normal, but sometimes, these struggles can feel overwhelming. If you find yourself ...

Please provide your email address to receive an email when new articles are posted on . Social stigma and pruritus impact the mental health of patients with atopic dermatitis. Reduced risks persisted ...

SAN FRANCISCO (KGO) -- The Department of Homelessness and Supportive Housing estimates that more than half of San Francisco's unhoused population suffers from some kind of mental illness. Some can be ...

Biography Andreas Maercker, PhD, MD, completed his medical and psychological education in Halle/Saale and Berlin. He received his MD at Humboldt University and his PhD at Max Planck Institute for ...

Glasofer is an associate professor of clinical medical psychology at Columbia University Medical Center and a practicing clinical psychologist in New York City. Attia is a professor of psychiatry at ...

Exhaustion disorder (ED) was introduced to the Swedish version of the International Classification of Diseases, 10th edition (ICD-10) 2005. Primarily characterized by general fatigue and cognitive ...

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of naturally derived psilocybin-based therapeutics, today announced ...